In addition to pulmonary fibrosis, columnist Ann Reynoso is now also dealing with sleep apnea — both of which affect her ...
Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
La fibrosis pulmonar idiopática (FPI) es una enfermedad crónica y progresiva que afecta a los pulmones y provoca la formación de tejido cicatricial. Su causa exacta es desconocida, aunque se ...
Among patients with PPF, those treated with 60 mg of admilparant showed significant decreases in periostin, ferritin, and ...
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Boehringer Ingelheim has ended a decade of industrywide failures in idiopathic pulmonary fibrosis (IPF) by reporting a phase ...
A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Boehringer Ingelheim’s investigational compound nerandomilast, which targets the PDE4B enzyme involved in fibrosis and ...
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
El Hospital Clínico Universitario Virgen de la Victoria de Málaga ha acogido, coincidiendo con la celebración este sábado del Día Mundial de la Fibrosis Pulmonar, la primera escuela de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback